![](/img/cover-not-exists.png)
Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer
Y. Delpech, Y. Wu, K. R. Hess, L. Hsu, M. Ayers, R. Natowicz, C. Coutant, R. Rouzier, E. Barranger, G. N. Hortobagyi, D. Mauro, L. PusztaiVolume:
135
Language:
english
DOI:
10.1007/s10549-012-2194-2
Date:
September, 2012
File:
PDF, 357 KB
english, 2012